010-58156160-822
CNTo facilitate the internationalization of Chinese innovative brands by promoting and implementing the national Innovation Driven Development Strategy, enhancing the core competitiveness of innovative technology and advancing the process of strengthening the nation by technology and pharmaceutical development, China Pharmaceutical Innovation and Research Development Association (PhIRDA) and Suzhou Industrial Park have reached a consensus on co-hosting the “Dushu Lake Prize” Selection Activities of China Pharmaceutical Innovation Brand (herein after referred to as the Selection Activities) in 2018. Both sides will join hands to make the Selection Activities a fair, just, and open session.
The Selection Activities adopts the mechanism of expert recommendation. Any applications from enterprises shall not be taken into consideration. The selection will follow the peer review system of international innovation standards and scientific awards to set the awards for the most innovative drugs, figures (Chinese scientists) and financial institutions.
Vice Chairman of the Standing Committee of 11th National People’s Congress, Academician of Chinese Academy of Engineering (CAE)
Academician of Chinese Academy of Sciences (CAS), Researcher, Director of Academic Degree Committee of Shanghai Institute of Materia Medica (SIMM), CAS
Director of Institute of Materia Medica (IMM), Chinese Academy of Medical Sciences (CAMS)
Academician of CAE, Former President of China Academy of Chinese Medical Sciences, President of Tianjin University of Traditional Chinese Medicine
Academician of CAS, Researcher of SIMM, CAS
Academician of CAE, Researcher of National Vaccine and Serum Institute
Academician of CAE, Academician of the World Academy of Sciences
Academician of CAE, Chairman of the Academic Committee & Director of Key Laboratory,China Pharmaceutical University
Academician of CAS, Dean of Institutes of Biomedical Sciences, Fudan University, Director of Cardiology Department of Zhongshan Hospital, Fudan University
Academician of CAS, Professor of National Key Laboratory of Biotherapy, Sichuan University
Academician of CAS, President of Shanghai Institutes for Biological Sciences, CAS
Academician of CAE, Vice President of Beijing University of Chemical Technology
Academician of CAS, Researcher of SIMM, CAS
Academician of CAE, Director of Department of Gastroenterology of Changhai Hospital of Shanghai
Academician of CAS, Foreign Academician of National Academy of Sciences, United States
Academician of CAE, Director of The National Center for Science in Hepatocellular Carcinoma
Academician of CAE, Honorary President/Principal of Shandong First Medical University & Shandong Academy of Medical Sciences
Academician of CAE, Vice President of Ruijin Hospital, Shanghai Jiaotong University
Academician of CAE, Chief Expert for Biological Product Testing in National Institutes for Food and Drug Control (NIFDC)
President of China Pharmaceutical University
Professor of Shenyang Pharmaceutical University
Professor & Former President of China Pharmaceutical University
Director of Department of Pharmacology of IMM, CAMS
President of Beijing Cancer Hospital
Executive Deputy Dean of Beijing Tiantan Hospital, Capital Medical University
Deputy Director of National Cancer Center, Vice President of Cancer Hospital, CAMS
President of Peking Union Medical College Hospital, vice president of China Alliance for Rare Diseases
Tenured Professor & Director of Guangdong General Hospital (GGH)
President of the Second Xiangya Hospital of Central South University
Director of Cancer Center of General Hospital of Eastern Theater Command
Director of Department of Cardiology and Heart Center, Peking University First Hospital
Executive Vice President of Sun Yat-Sen University Cancer Center
Chief Scientist at SDIC, Former Chief Scientist at Center for Drug Evaluation of NMPA
Director of Department of Hematology of Renji Hospital of Shanghai Jiaotong University School of Medicine
Director of Department of Neuro-Oncology of Beijing Tiantan Hospital, Capital Medical University
Director of SIMM, CAS, Director of State Key Laboratory of Drug Research
Vice President, Director of Cancer Center of Peking University International Hospital
Director of Harbin Institute of Hematology
Director of Oncology Department, Chinese PLA General Hospital
Director of the Department of Endocrine and Metabolism of Ruijin Hospital
DirectorDirector of Neurology Department of Air Force General Hospital, PLA
ChiefDirector of the Oncology Medicine Department of Beijing Chest Hospital, Capital Medical University
Director of Department of Neurology of Huashan Hospital
Director of Department of Gastroenterology, Chinese PLA General Hospital
Director of Department of Oncology of Shanghai East Hospital, Tongji University
Director of National Engineering Research Center for the Emergency Drug
Researcher of Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
Director of Medicine Economic Research Institute of School of Pharmaceutical Sciences, Sun Yat-Sen University
Vice Chairman of the Committee of Genetic Engineering Drugs
Tenure Professor and Department Head of Duke University Medical Center
Co-founder, President and Head of R&D of Kira Pharmaceuticals
Director of Center for Drug Safety Evaluation and Research of SIMM, CAS
Director of New Drug Clinical Trial Center of Beijing Shijitan Hospital, Capital Medical University
Director of Clinical Trial Center, Peking University First Hospital
Director of Department of Pharmacy, Beijing Hospital
Director of Department of Pharmacy, Beijing Childrens Hospital, Capital Medical University
Director of Beijing Hospital Clinical Trial Research Center (BJH-CTC)
Chairman of China Pharmaceutical Innovation and Research Development Association (PhIRDA)